Clinical Trial Update: Safety and Immunogenicity Study of a Candidate Tuberculosis Vaccine in Human Immunodeficiency Virus (HIV)-Positive Adults [Phase 2]

View source ↗

Summary

Phase 2 safety and immunogenicity trial of a tuberculosis vaccine candidate in HIV-positive adults completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberculosis

Drugs mentioned

• Tuberculosis vaccine candidate (unspecified)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Tuberculosis | Phase 2 | Status: COMPLETED | Results posted: 2018-09-17